271 related articles for article (PubMed ID: 37775649)
1. Interplay between signal transducers and activators of transcription (STAT) proteins and cancer: involvement, therapeutic and prognostic perspective.
Jill N; Bhootra S; Kannanthodi S; Shanmugam G; Rakshit S; Rajak R; Thakkar V; Sarkar K
Clin Exp Med; 2023 Dec; 23(8):4323-4339. PubMed ID: 37775649
[TBL] [Abstract][Full Text] [Related]
2. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.
Reddy EP; Korapati A; Chaturvedi P; Rane S
Oncogene; 2000 May; 19(21):2532-47. PubMed ID: 10851052
[TBL] [Abstract][Full Text] [Related]
3. Signaling through the JAK/STAT pathway, recent advances and future challenges.
Kisseleva T; Bhattacharya S; Braunstein J; Schindler CW
Gene; 2002 Feb; 285(1-2):1-24. PubMed ID: 12039028
[TBL] [Abstract][Full Text] [Related]
4. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus.
Heim MH
J Recept Signal Transduct Res; 1999; 19(1-4):75-120. PubMed ID: 10071751
[TBL] [Abstract][Full Text] [Related]
5. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
Carlesso N; Frank DA; Griffin JD
J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
[TBL] [Abstract][Full Text] [Related]
6. The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs).
Pellegrini S; Dusanter-Fourt I
Eur J Biochem; 1997 Sep; 248(3):615-33. PubMed ID: 9342212
[TBL] [Abstract][Full Text] [Related]
7. JAK/STAT signaling pathways and cancer. Janus kinases/signal transducers and activators of transcription.
Boudny V; Kovarik J
Neoplasma; 2002; 49(6):349-55. PubMed ID: 12584581
[TBL] [Abstract][Full Text] [Related]
8. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
Buettner R; Mora LB; Jove R
Clin Cancer Res; 2002 Apr; 8(4):945-54. PubMed ID: 11948098
[TBL] [Abstract][Full Text] [Related]
9. Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) in hematopoietic cells.
Nosaka T; Kitamura T
Int J Hematol; 2000 Jun; 71(4):309-19. PubMed ID: 10905049
[TBL] [Abstract][Full Text] [Related]
10. Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation.
Chaturvedi P; Reddy MV; Reddy EP
Oncogene; 1998 Apr; 16(13):1749-58. PubMed ID: 9582023
[TBL] [Abstract][Full Text] [Related]
11. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
[TBL] [Abstract][Full Text] [Related]
12. The role of STATs in transcriptional control and their impact on cellular function.
Bromberg J; Darnell JE
Oncogene; 2000 May; 19(21):2468-73. PubMed ID: 10851045
[TBL] [Abstract][Full Text] [Related]
13. Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors.
Pelletier S; Duhamel F; Coulombe P; Popoff MR; Meloche S
Mol Cell Biol; 2003 Feb; 23(4):1316-33. PubMed ID: 12556491
[TBL] [Abstract][Full Text] [Related]
14. Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children.
Freeth JS; Silva CM; Whatmore AJ; Clayton PE
Endocrinology; 1998 Jan; 139(1):20-8. PubMed ID: 9421393
[TBL] [Abstract][Full Text] [Related]
15. JAK-STAT signaling activated by Abl oncogenes.
Danial NN; Rothman P
Oncogene; 2000 May; 19(21):2523-31. PubMed ID: 10851051
[TBL] [Abstract][Full Text] [Related]
16. Members of the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway are present and active in human sperm.
D'Cruz OJ; Vassilev AO; Uckun FM
Fertil Steril; 2001 Aug; 76(2):258-66. PubMed ID: 11476770
[TBL] [Abstract][Full Text] [Related]
17. Jak-STAT signaling pathways in cells of the immune system.
Ivashkiv LB
Rev Immunogenet; 2000; 2(2):220-30. PubMed ID: 11258419
[TBL] [Abstract][Full Text] [Related]
18. STAT signaling in the pathogenesis and treatment of cancer.
Frank DA
Mol Med; 1999 Jul; 5(7):432-56. PubMed ID: 10449805
[TBL] [Abstract][Full Text] [Related]
19. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Janus kinase 2 by cisplatin in cancer cells.
Song H; Sondak VK; Barber DL; Reid TJ; Lin J
Int J Oncol; 2004 Apr; 24(4):1017-26. PubMed ID: 15010843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
